INTERNATIONAL PATENT: QUANTA THERAPEUTICS, INC. FILES APPLICATION FOR "COMBINATION CANCER THERAPIES WITH A KRAS MODULATOR AND AN RTK-MAPK PATHWAY INHIBITOR"

GENEVA, May 28 -- QUANTA THERAPEUTICS, INC. (2 Tower Place,Floor 14South San Francisco, California 94080) filed a patent application (PCT/US2024/056246) for "COMBINATION CANCER THERAPIES WITH A KRAS MODULATOR AND AN RTK-MAPK PATHWAY INHIBITOR" on Nov 15, 2024. With publication no. WO/2025/106901, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIN, Hong (c/o 2 Tower Place,Floor 14South San Francisco, California 94080), PITT, Cameron (c/o 2 Tower Place,Floor 14South San Francisco, California 94080)

Abstract: Provided he...